Anti-inflammatory therapy for cardiovascular disease.

scientific article

Anti-inflammatory therapy for cardiovascular disease. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.21037/ATM.2019.02.34
P932PMC publication ID6511577
P698PubMed publication ID31157268

P2093author name stringMario J Garcia
Constantine E Kosmas
Andreas Sourlas
Delia Silverio
Eliscer Guzman
Peter D Montan
P2860cites workLeukotrienes as modifiers of preclinical atherosclerosis?Q27025129
Hydroxychloroquine for autoimmune diseasesQ28066201
Colchicine--Update on mechanisms of action and therapeutic usesQ28082473
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesisQ28205296
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritisQ28709376
Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activationQ30447476
Phospholipase A(2) enzymes in metabolic and cardiovascular diseasesQ33773427
Anti-inflammatory therapies for cardiovascular diseaseQ34137872
Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.Q34151396
Phospholipase A(2) in vascular diseaseQ34339322
Cytokines in atherosclerosis: pathogenic and regulatory pathwaysQ34511711
Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered miceQ34598093
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritisQ34648366
Methotrexate in atherogenesis and cholesterol metabolismQ34757801
Endothelial function testing as a biomarker of vascular diseaseQ35569232
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control studyQ35605663
Activin A and follistatin in systemic inflammationQ35903331
A meta-analysis of proinflammatory cytokines in chronic heart failureQ36057476
Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis PatientsQ36877859
Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritisQ36964861
Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophagesQ37008144
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort studyQ37153680
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claimsQ37308677
Activin, neutrophils, and inflammation: just coincidence?Q38079493
Inflammation in coronary artery disease.Q38179830
Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery diseaseQ38265002
Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.Q38375421
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialQ38424365
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trialQ38441000
The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosusQ38446538
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseQ38606033
Association of neutrophils and future cardiovascular events in patients with peripheral artery diseaseQ40425085
Induction of inflammatory cytokine release from cultured human monocytes by C-reactive proteinQ41098875
Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implicationsQ41921823
Activin A Predicts Left Ventricular Remodeling and Mortality in Patients with ST-Elevation Myocardial Infarction.Q42033846
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscleQ44382946
From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammationQ44711070
Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study.Q44878173
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyQ44973310
Potential anti-inflammatory role of activin A in acute coronary syndromesQ44984913
Low-dose colchicine for secondary prevention of cardiovascular diseaseQ46245044
C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunctionQ46656237
Neutrophil count and infarct size in patients with acute myocardial infarction.Q47409029
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography StudyQ47620876
The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patientsQ49787347
Increased activin A levels in prediabetes and association with carotid intima-media thickness: a cross-sectional analysis from I-Lan Longitudinal Aging Study.Q55457462
Hydroxychloroquine: An old drug with new relevanceQ56379263
Darapladib for Preventing Ischemic Events in Stable Coronary Heart DiseaseQ57243317
Platelets in atherosclerosisQ63916904
LeukotrienesQ81542824
Activin A and cardiovascular disease in type 2 diabetes mellitusQ83207389
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndromeQ84127561
Baseline leukocyte count and acute coronary syndrome: predictor of adverse cardiac events, long and short-term mortality and association with traditional risk factors, cardiac biomarkers and C-reactive proteinQ85170105
Activin A in Mammalian PhysiologyQ90424447
The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular DiseaseQ90789713
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsQ92980641
P433issue7
P304page(s)147
P577publication date2019-04-01
P1433published inAnnals of Translational MedicineQ26842362
P1476titleAnti-inflammatory therapy for cardiovascular disease.
P478volume7

Reverse relations

cites work (P2860)
Q94571766Risk factors for cardiovascular disease from a population-based screening study in Tianjin, China: a cohort study of 36,215 residents
Q89978075Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis
Q89831534Sweet and Sticky: Selective Recruitment of Monocyte Subsets by Endothelial N-Glycans
Q89640159The atheroprotective roles of heart-protecting musk pills against atherosclerosis development in apolipoprotein E-deficient mice
Q98186313The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome

Search more.